Inventor · disambiguated record
Blaine Bueche
Also filed as: BUECHE BLAINE
7 granted patents·11 pending applications·176 citations·filing 2002–2023
84Inventor score
Files withAERAMI THERAPEUTICS INC4NEKTAR THERAPEUTICS4FORSIGHT VISION4 INC3DANCE BIOPHARM INC2ELIXIR MEDICAL CORP2
Top patents by PatentIndex Score
18 records- 0197US6838076B2Pulmonary administration of chemically modified insulinNEKTAR THERAPEUTICS·Filed 2002·Granted Jan 4, 2005·134 cites·44 claims
- 0296US11065151B2Therapeutic agent formulations for implanted devicesFORSIGHT VISION4 INC·Filed 2020·Granted Jul 20, 2021·3 cites·14 claims
- 0390US6890518B2Compositions of chemically modified insulinNEKTAR THERAPEUTICS·Filed 2003·Granted May 10, 2005·32 cites·19 claims
- 0488US10874548B2Therapeutic agent formulations for implanted devicesFORSIGHT VISION4 INC·Filed 2017·Granted Dec 29, 2020·2 cites·16 claims
- 0587US9968603B2Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implantFORSIGHT VISION4 INC·Filed 2014·Granted May 15, 2018·5 cites·22 claims
- 0665US11096990B2Liquid insulin formulations and methods relating theretoAERAMI THERAPEUTICS INC·Filed 2018·Granted Aug 24, 2021·0 cites·14 claims
- 0764US2005152848A1Pulmonary administration of chemically modified insulinFiled 2004·Application pending·0 cites
- 0863US2023165874A1Anticoagulant compounds and methods and devices for their pulmonary useELIXIR MEDICAL CORP·Filed 2023·Application pending·0 cites
- 0963US2011171312A1Modified therapeutic peptides, methods of their preparation and useNEKTAR THERAPEUTICS·Filed 2009·Application pending·0 cites
- 1062US2023293540A1Anticoagulant compounds, methods and devices for ophthalmic useELIXIR MEDICAL CORP·Filed 2023·Application pending·0 cites
- 1161US2014031769A1Therapeutic agent formulations for implanted devicesDE JUAN JR EUGENE·Filed 2011·Application pending·0 cites
- 1260US10842951B2Liquid insulin formulations and methods relating theretoAERAMI THERAPEUTICS INC·Filed 2018·Granted Nov 24, 2020·0 cites·42 claims
- 1355US2025177372A1Liquid formulations of indacaterol and glycopyrroniumAERORX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1450US2019343768A1Insulin formulations for reconstitution into high concentration liquid solutionsDANCE BIOPHARM INC·Filed 2019·Application pending·0 cites
- 1550US2016243199A1Liquid insulin formulations and methods relating theretoDANCE BIOPHARM INC·Filed 2015·Application pending·0 cites
- 1650US2006018840A1Aerosolizable formulation comprising nicotineNEKTAR THERAPEUTICS·Filed 2005·Application pending·0 cites
- 1749US2022249618A1Exenatide compositions for pulmonary administration and use thereofAERAMI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1845US2021228824A1Wicking cap and methodsAERAMI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Blaine Bueche files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →